Deal Announcements

Barofold Snags Series A Financing Of $12 Million

Tuesday, May 29, 2007 5:00:00 AM PDT | VentureDeal Staff

BOULDER, CO -- Biotechnology company Barofold, Inc. said that it closed a series A round of venture capital financing that totalled $12 million.

Barofold has developed technology that it licenses to companies wishing to disaggregate, refold and formulate protein biotherapeutic substances.  The company also has its own therapeutics pipeline, including a proprietary product candidate being developed to treat multuple sclerosis.

Investors in the round were co-leaders HBM Bioventures and Boulder Ventures.  Funding proceeds will be used to fund additional product development.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1